Wheeled Knee Walker for Diabetic Foot
Trial Summary
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if your medications cause impaired balance or judgment, you may not be eligible to participate.
What data supports the effectiveness of the Wheeled Knee Walker treatment for diabetic foot?
The Wheeled Knee Walker is shown to be a satisfactory assistive device for people recovering from foot or ankle surgery, with most users reporting satisfaction despite some experiencing falls. This suggests it may be a helpful tool for mobility and potentially beneficial for diabetic foot care by reducing weight-bearing stress, similar to other offloading devices used for diabetic foot ulcers.12345
Is the Wheeled Knee Walker safe for use?
How is the Wheeled Knee Walker treatment different from other treatments for diabetic foot?
The Wheeled Knee Walker (WKW) is unique because it provides a non-weightbearing way to move around, which can help protect and heal diabetic foot ulcers by reducing stress on the foot. Unlike traditional crutches or removable cast walkers, the WKW allows for easier mobility and may be more comfortable, although it requires proper instruction to prevent falls.23489
What is the purpose of this trial?
The increasing incidence of diabetes and high risk of amputation makes prevention and successful treatment of DFU of vital importance. A relatively new device, the wheeled knee walker, allows total offloading of the affected foot and, when compared to traditional walking aids such as crutches and walkers, requires significantly less physical exertion, is easier to use, and affords more stability. Its potential benefit to improve wound healing, impact physical function and quality of life in people with DFU is not yet known. Therefore, the goal of this research is to determine whether providing a wheeled knee walker to people with diabetic foot ulcers improves clinical outcomes and quality of life when compared to usual and customary care.
Research Team
Audrey R Zucker-Levin, PhD
Principal Investigator
University of Saskatchewan
Eligibility Criteria
This trial is for individuals with diabetes and a specific type of foot ulcer (grade 1A). Participants must be under a doctor's care, weigh no more than 300lbs, be over 18 years old, mentally capable, have phone access, and at least one palpable foot pulse. Excluded are those with active infections or severe health conditions like heart failure or recent strokes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Standardized baseline measures for each objective are performed
Treatment
Participants receive usual and customary care, with half receiving a wheeled knee walker
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Wheeled Knee Walker
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Saskatchewan
Lead Sponsor
Saskatchewan Health Research Foundation
Collaborator